ANI Pharmaceuticals files insider notice to sell 56,960 shares

Rhea-AI Filing Summary

ANI Pharmaceuticals, Inc. (ANIP) filed a Form 144 notifying a proposed sale of 56,960 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ with an aggregate market value of $4,894,823.42. The form lists the approximate date of sale as 08/12/2025 and reports 21,688,772 shares outstanding for the issuer.

The securities to be sold were acquired as restricted stock from the issuer on four dates in 2025: 02/14 (12,333 shares), 02/28 (11,666), 03/07 (16,292), and 03/23 (16,669), which total the 56,960 shares listed for sale. The filing also states "Nothing to Report" for securities sold during the past three months and includes the standard signer representation that they do not possess undisclosed material adverse information. Certain filer identification and contact fields in the filing appear blank in the provided content.

Insights

Securities Analyst

TL;DR: Routine Form 144 notice for a proposed sale of 56,960 restricted shares; filing is informational and procedural.

The filing documents a planned brokered sale on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $4,894,823.42. Acquisition details show these shares were granted as restricted stock by the issuer on specific dates in early 2025, and the filer reports no securities sold in the prior three months. From a market-impact perspective, the form is a standard insider-disposal notice that notifies the market but does not itself convey new operational or financial performance information about the company.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; verifies insider sale mechanics but lacks complete filer contact/CIK data in the provided text.

The document fulfills the Rule 144 notice requirement by specifying class, broker, quantity, aggregate value, and acquisition history of the securities. It also includes the signer's representation about absence of undisclosed material adverse information. Notably, filer identification and submission contact details are blank in the supplied content, which is a procedural omission that should be resolved in the official filing record to ensure traceability and regulatory compliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	56960	4894823.42	21688772	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/23/2025	Restricted Stock	Issuer			16669	03/23/2025	Not Applicable
Common	03/07/2025	Restricted Stock	Issuer			16292	03/07/2025	Not Applicable
Common	02/28/2025	Restricted Stock	Issuer			11666	02/28/2025	Not Applicable
Common	02/14/2025	Restricted Stock	Issuer			12333	02/14/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ANIP Form 144 state about the proposed sale?

The Form 144 notifies a proposed sale of 56,960 shares of common stock with an aggregate market value of $4,894,823.42, to be sold via Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate sale date of 08/12/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired as restricted stock from the issuer on four dates in 2025: 02/14 (12,333), 02/28 (11,666), 03/07 (16,292), and 03/23 (16,669).

Does the filing report any securities sold in the past three months for ANIP?

The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker named in the Form 144 for ANIP?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Are there any missing procedural details in the provided Form 144 excerpt?

Yes. The provided content shows blank fields for Filer CIK, filer contact name, phone, and email in the excerpt.